Results 221 to 230 of about 1,436,185 (319)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

The effects of extracorporeal shockwave therapy on bone mineral density and microarchitecture in animal models of osteoporosis: a systematic review and meta-analysis. [PDF]

Front Rehabil Sci
Wen X, Xiangli J, He Q, Yin Z.
europepmc   +1 more source

Modeling of electromagnetic wave reflection from wet soil taken into account of dispersion, heterogeneity and surface roughness

D.N. Panin, Oleg V. Osipov
openalex   +2 more sources

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Figure S2 from A comparative study of neuroendocrine heterogeneity in small cell lung cancer and neuroblastoma

Ling Cai, Ralph J. DeBerardinis, Yang Xie, John D. Minna, Guanghua Xiao   +4 more
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Effects of Tai Chi on balance and fall prevention in healthy older adults: a randomized controlled meta-analysis. [PDF]

Front Public Health
Dong R, Hamzah MSGB, Awang MMB, Qiu J, Chen S.   +4 more
europepmc   +1 more source

Data from Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis

Ibrahim Chamseddine, Keyur D Shah, Hoyeon Lee, Felix Ehret, Jan Schuemann, Alejandro Bertolet, Helen A. Shih, Harald Paganetti   +7 more
openalex   +1 more source